Shares of Immunovant, Inc. (NASDAQ:IMVT – Get Free Report) have been given an average rating of “Moderate Buy” by the ten ...

JNJ's filing seeks the FDA's approval for nipocalimab to treat generalized myasthenia gravis in a broad population of ...

Pediatric patients with sickle cell anemia and a history of abnormal cerebral artery velocities had reduced hospitalizations ...

The diagnosis of hemolytic anemia was established mainly by the clinical observation of either a fall in circulating hemoglobin levels or a loss of transfused blood in excess of 1 per cent per day.

Physicians or patients who wish to participate in the 60 Degrees Pharmaceuticals Tafenoquine for Babesiosis Expanded Access clinical study are encouraged to visit the Company’s website for information ...

A 14-year-old patient presented to the ED with a 12-month history of joint pains and a 2-month history of headaches and ...

Johnson & Johnson has won Food and Drug Administration priority review for its application seeking approval of nipocalimab in certain patients with generalized myasthenia gravis.

KARACHI: Elephant Sonia housed at the Safari Park suffered from multiple chronic illnesses, affecting almost all vital organs ...

Agios Pharmaceuticals, Inc. (AGIO), on Wednesday, announced that its supplemental New Drug Application seeking approval for the ...

The European Commission has granted orphan drug status to mitapivat, an oral investigational therapy for sickle cell disease.

Expresses differences in erythrocyte size in an individual specimen Used to detect anisocytosis. Increased in immune hemolytic anemia, SS and SC disease, and hereditary spherocytosis ...